EXAS vs PTN · rev $2.76B vs P/E 111, $21.8M cap
EXACT Sciences Corporation (EXAS) versus Palatin Technologies, Inc. Common Stock (PTN) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Palatin Technologies, Inc. Common Stock (PTN) is a biotechnology company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported PTN revenue for 2025-06-30 was $0. Net income was -$17.3M. PTN currently screens at market cap $21.8M and trailing P/E 111.4.
EXAS currently screens at market cap $20.03B. PTN currently screens at market cap $21.8M and trailing P/E 111.4.
Not investment advice. Open the EXAS and PTN stock pages for the full models.
Not investment advice.